PFIZER | PROCTER & GAMBLE HEALTH | PFIZER/ PROCTER & GAMBLE HEALTH |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 38.2 | 34.5 | 110.8% | View Chart |
P/BV | x | 6.0 | 10.5 | 56.9% | View Chart |
Dividend Yield | % | 1.7 | 2.0 | 82.7% |
PFIZER PROCTER & GAMBLE HEALTH |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PFIZER Mar-23 |
PROCTER & GAMBLE HEALTH Jun-23 |
PFIZER/ PROCTER & GAMBLE HEALTH |
5-Yr Chart Click to enlarge
|
||
High | Rs | 4,662 | 5,366 | 86.9% | |
Low | Rs | 3,407 | 3,883 | 87.7% | |
Sales per share (Unadj.) | Rs | 530.0 | 740.7 | 71.6% | |
Earnings per share (Unadj.) | Rs | 136.4 | 138.2 | 98.7% | |
Cash flow per share (Unadj.) | Rs | 159.4 | 155.2 | 102.8% | |
Dividends per share (Unadj.) | Rs | 70.00 | 95.00 | 73.7% | |
Avg Dividend yield | % | 1.7 | 2.1 | 84.5% | |
Book value per share (Unadj.) | Rs | 701.0 | 447.6 | 156.6% | |
Shares outstanding (eoy) | m | 45.75 | 16.60 | 275.6% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 7.6 | 6.2 | 121.9% | |
Avg P/E ratio | x | 29.6 | 33.5 | 88.4% | |
P/CF ratio (eoy) | x | 25.3 | 29.8 | 84.9% | |
Price / Book Value ratio | x | 5.8 | 10.3 | 55.7% | |
Dividend payout | % | 51.3 | 68.7 | 74.7% | |
Avg Mkt Cap | Rs m | 184,576 | 76,761 | 240.5% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 3,317 | 2,062 | 160.9% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 24,248 | 12,296 | 197.2% | |
Other income | Rs m | 1,011 | 184 | 549.5% | |
Total revenues | Rs m | 25,258 | 12,480 | 202.4% | |
Gross profit | Rs m | 8,420 | 3,247 | 259.3% | |
Depreciation | Rs m | 1,055 | 281 | 375.5% | |
Interest | Rs m | 135 | 8 | 1,750.6% | |
Profit before tax | Rs m | 8,240 | 3,142 | 262.3% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 2,001 | 847 | 236.1% | |
Profit after tax | Rs m | 6,239 | 2,295 | 271.9% | |
Gross profit margin | % | 34.7 | 26.4 | 131.5% | |
Effective tax rate | % | 24.3 | 27.0 | 90.0% | |
Net profit margin | % | 25.7 | 18.7 | 137.9% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 24,933 | 11,713 | 212.9% | |
Current liabilities | Rs m | 6,574 | 6,791 | 96.8% | |
Net working cap to sales | % | 75.7 | 40.0 | 189.2% | |
Current ratio | x | 3.8 | 1.7 | 219.9% | |
Inventory Days | Days | 93 | 263 | 35.6% | |
Debtors Days | Days | 2 | 343 | 0.7% | |
Net fixed assets | Rs m | 13,780 | 10,617 | 129.8% | |
Share capital | Rs m | 458 | 166 | 275.6% | |
"Free" reserves | Rs m | 31,616 | 7,265 | 435.2% | |
Net worth | Rs m | 32,073 | 7,431 | 431.6% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 39,031 | 22,330 | 174.8% | |
Interest coverage | x | 62.1 | 409.1 | 15.2% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.6 | 0.6 | 112.8% | |
Return on assets | % | 16.3 | 10.3 | 158.4% | |
Return on equity | % | 19.5 | 30.9 | 63.0% | |
Return on capital | % | 26.1 | 42.4 | 61.6% | |
Exports to sales | % | 2.8 | 0 | - | |
Imports to sales | % | 0 | 13.1 | 0.3% | |
Exports (fob) | Rs m | 688 | NA | - | |
Imports (cif) | Rs m | 8 | 1,605 | 0.5% | |
Fx inflow | Rs m | 688 | 1,465 | 46.9% | |
Fx outflow | Rs m | 8 | 1,605 | 0.5% | |
Net fx | Rs m | 679 | -140 | -484.6% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 3,557 | 2,360 | 150.7% | |
From Investments | Rs m | -361 | -215 | 167.7% | |
From Financial Activity | Rs m | -3,458 | -985 | 351.2% | |
Net Cashflow | Rs m | -262 | 1,160 | -22.5% |
Indian Promoters | % | 0.0 | 0.0 | - | |
Foreign collaborators | % | 63.9 | 51.8 | 123.4% | |
Indian inst/Mut Fund | % | 18.2 | 20.3 | 89.7% | |
FIIs | % | 3.0 | 7.6 | 39.9% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 36.1 | 48.2 | 74.9% | |
Shareholders | 112,456 | 56,730 | 198.2% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PFIZER With: CIPLA DIVIS LABORATORIES SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Pfizer | Procter & Gamble Health | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -4.80% | -0.55% | 1.18% |
1-Month | -8.24% | -7.47% | -0.75% |
1-Year | 21.78% | -3.02% | 61.82% |
3-Year CAGR | -2.07% | -9.12% | 18.16% |
5-Year CAGR | 4.95% | 5.75% | 19.79% |
* Compound Annual Growth Rate
Here are more details on the Pfizer share price and the Procter & Gamble Health share price.
Moving on to shareholding structures...
The promoters of Pfizer hold a 63.9% stake in the company. In case of Procter & Gamble Health the stake stands at 51.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Pfizer and the shareholding pattern of Procter & Gamble Health.
Finally, a word on dividends...
In the most recent financial year, Pfizer paid a dividend of Rs 70.0 per share. This amounted to a Dividend Payout ratio of 51.3%.
Procter & Gamble Health paid Rs 95.0, and its dividend payout ratio stood at 68.7%.
You may visit here to review the dividend history of Pfizer, and the dividend history of Procter & Gamble Health.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.